806 related articles for article (PubMed ID: 28183310)
1. Animal models of hyperandrogenism and ovarian morphology changes as features of polycystic ovary syndrome: a systematic review.
Paixão L; Ramos RB; Lavarda A; Morsh DM; Spritzer PM
Reprod Biol Endocrinol; 2017 Feb; 15(1):12. PubMed ID: 28183310
[TBL] [Abstract][Full Text] [Related]
2. Characterization of reproductive, metabolic, and endocrine features of polycystic ovary syndrome in female hyperandrogenic mouse models.
Caldwell AS; Middleton LJ; Jimenez M; Desai R; McMahon AC; Allan CM; Handelsman DJ; Walters KA
Endocrinology; 2014 Aug; 155(8):3146-59. PubMed ID: 24877633
[TBL] [Abstract][Full Text] [Related]
3. Ovarian size and blood flow in women with polycystic ovary syndrome and their correlations with endocrine parameters.
Carmina E; Orio F; Palomba S; Longo RA; Lombardi G; Lobo RA
Fertil Steril; 2005 Aug; 84(2):413-9. PubMed ID: 16084883
[TBL] [Abstract][Full Text] [Related]
4. Chronic hyperandrogenemia in the presence and absence of a western-style diet impairs ovarian and uterine structure/function in young adult rhesus monkeys.
Bishop CV; Mishler EC; Takahashi DL; Reiter TE; Bond KR; True CA; Slayden OD; Stouffer RL
Hum Reprod; 2018 Jan; 33(1):128-139. PubMed ID: 29190387
[TBL] [Abstract][Full Text] [Related]
5. Polycystic Ovary Syndrome.
Azziz R
Obstet Gynecol; 2018 Aug; 132(2):321-336. PubMed ID: 29995717
[TBL] [Abstract][Full Text] [Related]
6. Polycystic ovaries are common in women with hyperandrogenic chronic anovulation but do not predict metabolic or reproductive phenotype.
Legro RS; Chiu P; Kunselman AR; Bentley CM; Dodson WC; Dunaif A
J Clin Endocrinol Metab; 2005 May; 90(5):2571-9. PubMed ID: 15713728
[TBL] [Abstract][Full Text] [Related]
7. The polycystic ovary syndrome-associated gene Yap1 is regulated by gonadotropins and sex steroid hormones in hyperandrogenism-induced oligo-ovulation in mouse.
Ji SY; Liu XM; Li BT; Zhang YL; Liu HB; Zhang YC; Chen ZJ; Liu J; Fan HY
Mol Hum Reprod; 2017 Oct; 23(10):698-707. PubMed ID: 28961951
[TBL] [Abstract][Full Text] [Related]
8. Hormone-induced rat model of polycystic ovary syndrome: A systematic review.
Noroozzadeh M; Behboudi-Gandevani S; Zadeh-Vakili A; Ramezani Tehrani F
Life Sci; 2017 Dec; 191():259-272. PubMed ID: 29055801
[TBL] [Abstract][Full Text] [Related]
9. Exercise training improved insulin sensitivity and ovarian morphology in rats with polycystic ovary syndrome.
Qiu S; Wu C; Lin F; Chen L; Huang Z; Jiang Z
Horm Metab Res; 2009 Dec; 41(12):880-5. PubMed ID: 19693748
[TBL] [Abstract][Full Text] [Related]
10. Interrelationship between excessive levels of circulating androgens in blood and ovulatory failure.
Parker CR; Mahesh VB
J Reprod Med; 1976 Aug; 17(2):75-90. PubMed ID: 134158
[TBL] [Abstract][Full Text] [Related]
11. A genetic risk score is associated with polycystic ovary syndrome-related traits.
Lee H; Oh JY; Sung YA; Chung HW
Hum Reprod; 2016 Jan; 31(1):209-15. PubMed ID: 26573528
[TBL] [Abstract][Full Text] [Related]
12. Comparison of clinical and laboratory characteristics of cases with polycystic ovarian syndrome based on Rotterdam's criteria and women whose only clinical signs are oligo/anovulation or hirsutism.
Hassa H; Tanir HM; Yildiz Z
Arch Gynecol Obstet; 2006 Jul; 274(4):227-32. PubMed ID: 16691383
[TBL] [Abstract][Full Text] [Related]
13. Ovarian morphology and endocrine function in polycystic ovary syndrome.
Tena G; Moran C; Romero R; Moran S
Arch Gynecol Obstet; 2011 Dec; 284(6):1443-8. PubMed ID: 21243502
[TBL] [Abstract][Full Text] [Related]
14. Reconciling the definitions of polycystic ovary syndrome: the ovarian follicle number and serum anti-Müllerian hormone concentrations aggregate with the markers of hyperandrogenism.
Dewailly D; Pigny P; Soudan B; Catteau-Jonard S; Decanter C; Poncelet E; Duhamel A
J Clin Endocrinol Metab; 2010 Sep; 95(9):4399-405. PubMed ID: 20610596
[TBL] [Abstract][Full Text] [Related]
15. Comparison of ovarian electrocautery and oral contraceptives in the treatment of hyperandrogenism in women with polycystic ovary syndrome.
Gjønnaess H
Acta Obstet Gynecol Scand; 1999 Jul; 78(6):530-3. PubMed ID: 10376864
[TBL] [Abstract][Full Text] [Related]
16. Modulation of steroidogenesis by vitamin D3 in granulosa cells of the mouse model of polycystic ovarian syndrome.
Bakhshalizadeh S; Amidi F; Alleyassin A; Soleimani M; Shirazi R; Shabani Nashtaei M
Syst Biol Reprod Med; 2017 Jun; 63(3):150-161. PubMed ID: 28345956
[TBL] [Abstract][Full Text] [Related]
17. Effects of long-term exogenous testosterone administration on ovarian morphology, determined by transvaginal (3D) ultrasound in female-to-male transsexuals.
Caanen MR; Schouten NE; Kuijper EAM; van Rijswijk J; van den Berg MH; van Dulmen-den Broeder E; Overbeek A; van Leeuwen FE; van Trotsenburg M; Lambalk CB
Hum Reprod; 2017 Jul; 32(7):1457-1464. PubMed ID: 28505246
[TBL] [Abstract][Full Text] [Related]
18. Excessive androgen exposure in female-to-male transsexual persons of reproductive age induces hyperplasia of the ovarian cortex and stroma but not polycystic ovary morphology.
Ikeda K; Baba T; Noguchi H; Nagasawa K; Endo T; Kiya T; Saito T
Hum Reprod; 2013 Feb; 28(2):453-61. PubMed ID: 23188113
[TBL] [Abstract][Full Text] [Related]
19. Circulating gonadotropins and ovarian adiponectin system are modulated by acupuncture independently of sex steroid or β-adrenergic action in a female hyperandrogenic rat model of polycystic ovary syndrome.
Maliqueo M; Benrick A; Alvi A; Johansson J; Sun M; Labrie F; Ohlsson C; Stener-Victorin E
Mol Cell Endocrinol; 2015 Sep; 412():159-69. PubMed ID: 25963796
[TBL] [Abstract][Full Text] [Related]
20. Polycystic ovary syndrome: possible involvement of androgen-induced, chemerin-mediated ovarian recruitment of monocytes/macrophages.
Lima PDA; Nivet AL; Wang Q; Chen YA; Leader A; Cheung A; Tzeng CR; Tsang BK
Biol Reprod; 2018 Oct; 99(4):838-852. PubMed ID: 29688269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]